CSTM 2025 Abstract Book - Click Here
Poster # | Poster Title | Presenting Author |
1 | Red blood cells from donors with diabetes are not differentially impacted by manufacturing stresses | Celina Phan |
2 | Investigating the Thaw-Time and Post Thaw Storage of Solvent Detergent (S/D) treated Plasma | Jeff Kinnery |
3 | Scoping review of social, ethical, and legal considerations of genomic sequencing | Kelly Holloway |
4 | Physician Management of Ig in Canada: A Qualitative Study | Kelly Holloway |
5 | A qualitative study of donors' views on uses of genomic sequencing in a blood donation context | Jennie Haw |
6 | Sera from Patients with Immune Platelet-Transfusion Refractoriness Primarily Drive FcɣRIII-Dependent Platelet Destruction In Vitro and Clearance In Vivo in a Humanized Mouse Model | Lazaro Gil Gonzalez |
7 | Differential Roles for the Coagulation Factor X Gla-Domain During Activation | Lihua Hao |
8 | Impact of Cannabis Use on Platelet Quality: Implications for Blood Donors | Lionel Loubaki |
9 | Comparative oxygen delivery potency of young and old red blood cells | Mahsa Yazdanbakhsh |
10 | New cryopreservation model provides new insights into the sensitivity of hematopoietic stem cell and progenitors to cryostorage | Nicolas Pineault |
11 | Temporal trending of seasonal Influenza and HIV-1&2 serological false positive results in blood donor testing | Nicole Vansenus |
12 | The ability of Cutibacterium acnes to establish chronic infections is heightened in the platelet storage environment | Sandra Ramirez-Arcos |
13 | Biofilm Formation by Acinetobacter baumannii Strains involved in Septic Transfusion Reactions is Stronger in Platelet Concentrates Prepared in 100% Plasma Compared to Platelet Additive Solution | Yuntong Kou |
14 | How to create evidence to re-evaluate universal syphilis testing for blood donors? | Sandra Ramirez-Arcos |
15 | Innovative Antifouling Bead-Based Platform for Identification of Novel Platelet Receptor Ligands | Sladjana Slavkovic |
16 | RBC quality when a prototype DEHP-free collection set is used with Canadian Blood Services whole blood-derived component production processes | Tatiana Stephenson |
17 | Evidence for Trogocytosis in RhIG-Mediated Immune Suppression: A Paradigm Shift in HDFN Prevention | Yoelys Cruz Leal |
18 | Cryopreservation of red blood cells with isochoric freezing | Yuanheng Zhao |
19 | Changes in Intravenous or Subcutaneous Immunoglobulin Usage Before and After Efgartigimod Initiation in Patients With Myasthenia Gravis | Alexis Fuhr |
20 | Sustainability and cost-avoidance of reduced inappropriate red cell transfusion at community hospitals: A follow-up analysis on a Quality Improvement initiative. | Alexis Fang |
21 | Unusual spike in PTP cases in Canada - Not so rare anymore? | Ann Peregrin |
22 | Impact of doctor's care on eligibility in Canadian blood donors | Anna Hu |
23 | Evaluation of the Seasonal Timing for Universal West Nile Virus Testing in Canadian Blood Donors: Is an Earlier Start Needed? | Carmen Charlton |
24 | High-Sensitivity Detection of Low-Level Malaria Parasitemia for Blood Donor Screening | Carmen Charlton |
25 | Oh Baby: A Review of Pregnancy Outcomes in Women with Bombay Phenotype | Catherine Lovatt |
26 | A unique example of a Cromer system antibody | Chris Kong |
27 | Asymptomatic West Nile Virus Positivity Amongst Canadian Blood Donors Compared to Clinically Reported Cases | Cynthia Cranney |
28 | Is there value in sharing donor information with other blood agencies? | Elaine Fournier |
29 | Utilization Performance Indicators: Improving Component Utilization Through Data Analysis and Visualizations. | Jennifer LeFrense |
30 | Exploring Physician-related Transfusion Errors reported to the Transfusion Error Surveillance System (TESS) from 2016-2023: A single centre study | Julia Lou |
31 | Transfusion practices and management for multi-transfused patients with Anti-Jsb alloimmunization. | Karen Kong |
32 | Analysis of Stem Cell Club Donor Recruitment Outcomes: Ten Years in Review | Margarita Conway |
33 | Antenatal immunohematology: a review of two large provincial testing programs | Lhevinne Ciurcovich |
34 | Empowering the Transfusion Medicine Community: The Impact of National Education | Crystal Brunk |
35 | A comparison of manual and automated gel technology vs manual saline indirect antiglobulin test in prenatal antibody titration | Melanie Bernabe |
36 | The impact of pathogen reduced platelet implementation on manufacturing and process metrics | Michelle Zeller |
37 | Impact of pathogen reduced platelet implementation on adverse transfusion reaction reporting | Michelle Zeller |
38 | Education and knowledge translation initiatives supporting pathogen reduced platelet implementation by a Canadian blood and biologic supplier | Michelle Zeller |
39 | Education and knowledge translation initiatives supporting solvent detergent plasma implementation by a national blood supplier | Kathryn Webert |
40 | Non-Invasive Prenatal Testing in Canada: Side-by-Side Evaluation of Two Platforms for Fetal RHD Screening | Narisha Shakuralli |
41 | Small volume platelet orders: Can aliquot validation improve platelet conservation? | Susan Nahirniak |
42 | Transfusion Service Transformation | Bryan Tordon |
43 | Bridging the Gap: Navigating document management after the loss of an eDMS | Jessica Okerman |
44 | Impact on solvent detergent plasma implementation on adverse transfusion reaction reporting | Nour Alhomsi |
45 | Emergency red blood cell utilization in Saskatchewan hold-blood sites: a 5-year audit | Oksana Prokopchuk-Gauk |
46 | Comparison of Frozen Plasma and Solvent-Detergent Plasma Thaw Times: A Single-Centre Validation Study | Oksana Prokopchuk-Gauk |
47 | Risk of high volume antenatal feto-maternal hemorrhage (FMH) in Rh negative pregnancies. What is the role of antenatal testing for FMH? | Sarah Tehseen |
48 | Turning the Tide: Transforming O RhD Negative RBC Management | Sarah McMahon |
49 | Platelet Intrauterine Fetal Transfusion | Shelley Anne Solomon |
50 | Anti-KEL1 titration in pregnancy: a method comparison study | Tammy Bartok |
51 | Creation of the Canadian Blood Group Genomic Reference Database: a Curated Tool to Support Precision Transfusion Medicine. | Teenus Paramel Jayaprakash |
52 | Manual Method versus ECHO Lumena DAT-C3d Test Validation | Wendy Kavanagh |
53 | Cost-effectiveness of reaching Ig self-sufficency targets using alternative treatments to reduce demand compared to increasing supply | Julien McDonald-Guimond |
54 | Automation and Workload Assessment in the Transfusion Medicine Laboratory | Susan Nahirniak |
55 | Reducing Unnecessary Type & Screen Testing in Planned C-Sections: A Provincial QI Approach | Susan Nahirniak |
56 | The National HLA/HPA Selected Platelet Program: Utilization trends in Canada | Natasha Rickards |
57 | Development and feasibility of a national prehospital transfusion registry: insights from the Blood on Board program at Ornge | Noah Zweig |
58 | Analysis of the 2024 IQMH patterns of practice survey on provision of transfusion services and blood products to affiliated laboratories, subsidiary facilities, and other programs. | Chang-Keun Lee |
59 | Exploration of Participant Responses to the 2024 IQMH Educational Survey and Discrepancies in Practice Across the Province. | Chang-Keun Lee |
60 | Cord DAT strength correlates with the need for neonatal phototherapy | Nora MacNeil |
61 | Comparative evaluation of automated column agglutination technique versus manual conventional tube isohemagglutinin titration in ABO-incompatible renal transplant | Jian Jing |
62 | Designing Canada's Blood Supply Chain for the 2030's | John Blake |
63 | Post-Pandemic Trends and Regional Variability in Red Blood Cell Issuance Across Canada | John Wall |
64 | Development of Knowledge Translation Toolkit for the Canadian Transfusion Trials Group | Kathryn Corbett |
65 | E-learning for Transfusion Consent: Developing a Novel Educational Tool | Marissa Laureano |
66 | Calculating Capacity: A Workload Model for Transfusion Medicine Physicians in Ontario | Marissa Laureano |
67 | Massive hemorrhage protocol activation in a tertiary hospital network: a 3-year retrospective quality improvement audit using quality indicators | Phillipe Price |
68 | Implementing Best Practice Guidelines for Sickle Cell Disease at a Community Teaching Hospital | Thodora Ruijs |
69 | Updating a provincial MHP through a modified Delphi: What has changed? | Stephanie Cope |
70 | Evolution of a Massive Hemorrhage Protocol Quality Metrics Portal | Alison Wendt |
71 | Compliance in Blood Administration: Insights from the 2023 Provincial Bedside Audit | Tracy Cameron |
Bowring 2